Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
As of Q1 2025, Veloxity Labs reported strong growth with over 63% year-over-year revenue increase and expanded analytical capacity. The company maintains high operational efficiency and rapid turnaround times for bioanalytical data delivery to support pharmaceutical and biotech clients in advancing their therapeutics through preclinical and clinical development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Veloxity Labs.